Ranitidine Tablets are indicated in: Short- term treatment of active duodenal ulcer. Most patients heal within 4 weeks.
From the U.S. FDA-approved label for Ranitidine. Full label: DailyMed.
Ranitidine Tablets are indicated in: Short- term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of Ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. No placebo- controlled comparative studies have been carried out for periods of longer than 1 year. The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome and systemic mastocytosis).
From the U.S. FDA-approved label for Ranitidine. Full label: DailyMed.
Active Duodenal Ulcer: The current recommended adult oral dosage of Ranitidine Tablets for duodenal ulcer is 150 mg twice daily. An alternative dosage of 300 mg once daily after the evening meal or at bedtime can be used for patients in whom dosing convenience is important. The advantages of one treatment regimen compared with the other in a particular patient population have yet to be demonstrated (see Clinical Trials: Active Duodenal Ulcer ).
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Ranitidine Tablets are contraindicated for patients known to have hypersensitivity to the drug or any of the ingredients (see PRECAUTIONS ).
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
General: Symptomatic response to therapy with Ranitidine Tablets does not preclude the presence of gastric malignancy. Since Ranitidine Tablets are excreted primarily by the kidney, dosage should be adjusted in patients with impaired renal function (see DOSAGE AND ADMINISTRATION ). Caution should be observed in patients with hepatic dysfunction since Ranitidine Tablets are metabolized in the liver. Rare reports suggest that Ranitidine Tablets may precipitate acute porphyric attacks in patients with acute porphyria. Ranitidine Tablets should therefore be avoided in patients with a history of acute porphyria.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following have been reported as events in clinical trials or in the routine management of patients treated with Ranitidine Tablets. The relationship to therapy with Ranitidine Tablets has been unclear in many cases. Headache, sometimes severe, seems to be related to administration of Ranitidine Tablets. Central Nervous System: Rarely, malaise, dizziness, somnolence, insomnia, and vertigo.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
300 products from 197 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Acidin 150mg Tablet | Ranitidine (150mg) | S.R. Drug Laboratories Pvt. Ltd. | |
| Aciloc 150mg Tablet | Ranitidine (150mg) | Cadila Pharmaceuticals Limited. | |
| Aciloc 300mg Tablet | Ranitidine (300mg) | Cadila Pharmaceuticals Limited. | |
| Aciloc Injection | Ranitidine | Cadila Pharmaceuticals Limited. | |
| Acitac S 150mg Tablet | Ranitidine (150mg) | G.D. Laboratories Pvt. Ltd. | |
| C-Rantin 150 150mg Tablet | Ranitidine (150mg) | Curex Pharmaceuticals Pvt. Ltd. | |
| Consec 150mg Tablet | Ranitidine (150mg) | Jagsonpal Pharmaceuticals Ltd. | |
| H-LOK 150mg Tablet | Ranitidine (150mg) | Mark Ltd. | |
| Hiloc 150mg Tablet | Ranitidine (150mg) | Chemidrug Industries Pvt. Ltd. | |
| Histabloc 25mg/ml Injection | Ranitidine (25mg/ml) | National Healthcare Pvt. Ltd. | |
| Histac 150mg Tablet | Ranitidine (150mg) | Sun Pharmaceutical Industries Ltd. | |
| Histac 300mg Tablet | Ranitidine (300mg) | Sun Pharmaceutical Industries Ltd. | |
| Histac EVT 150mg Tablet | Ranitidine (150mg) | Sun Pharmaceutical Industries Ltd. | |
| Neotack 150mg Tablet | Ranitidine (150mg) | Square Pharmaceuticals Ltd. | |
| Ortac 150mg Tablet | Ranitidine (150mg) | Orion Lab | |
| R-Loc 150mg Tablet | Ranitidine (150mg) | Zydus Pharmaceuticals | |
| R-Loc 50mg Injection | Ranitidine (50mg) | Zydus Pharmaceuticals | |
| R-TIN 150mg Tablet | Ranitidine (150mg) | Unique | |
| Ranial 150mg Tablet | Ranitidine (150mg) | Albert David Ltd. | |
| Ranidin 150mg Tablet | Ranitidine (150mg) | Acme Laboratories Ltd | |
| Renitab 150mg Tablet | Ranitidine (150mg) | Micro Labs Ltd. | |
| Rintin 150mg Tablet | Ranitidine (150mg) | Radicura Pharma Pvt Ltd | |
| Tagon 150mg Tablet | Ranitidine (150mg) | Apex Pharmaceuticals Pvt. Ltd. | |
| Ulcifuard 150mg Tablet | Ranitidine (150mg) | Saga Laboratories | |
| Ulfast 150mg Tablet | Ranitidine (150mg) | Sun Pharmaceutical Industries Ltd. | |
| Umetac 50mg Injection | Ranitidine (50mg) | Umedica | |
| Zantac 150mg Tablet | Ranitidine (150mg) | Glaxo SmithKline Pharmaceuticals Ltd. | |
| Zinetac 150mg Tablet | Ranitidine (150mg) | Glaxo SmithKline Pharmaceuticals Ltd. | |
| Zinetac 25mg/1ml Injection | Ranitidine (25mg/1ml) | Glaxo SmithKline Pharmaceuticals Ltd. | |
| Zinetac 300mg Tablet | Ranitidine (300mg) | Glaxo SmithKline Pharmaceuticals Ltd. |
Showing 30 of 300 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Keep the bottle tightly closed. Protect from light.
Storage information from the U.S. FDA-approved label.
Ranitidine is recorded in the NepalDoc medicine catalog for: Dyspepsia, H. pylori infection, Benign gastric and duodenal ulceration, GERD, Acid aspiration during general anesth, Prophylaxis during NSAID treatment.
For Dyspepsia: Famotidine, Magaldrate + Simethicone.
For H. pylori infection: Omeprazole, Pantoprazole, Rabeprazole.
For GERD: Magaldrate + Simethicone.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.